-
Posted by
Two Blokes Jul 17 -
Filed in
Stock
-
4 views
- Supporting Korean Startups' Drug Discovery Research and Global Expansion - - First Pharmaceutical Company from Japan to Actively Support the Operation of the Program - TOKYO , July 17, 2025 /PRNewswire/ -- Astellas Pharma Inc. (TSE: 4503, President and CEO: Naoki Okamura, "Astellas") today announced that it has agreed on a memorandum of understanding ("MoU") with the Korea Institute of Startup and Entrepreneurship Development (President: Jong-pil Yoo, "KISED"), an umbrella organization of the Ministry of SMEs and Startups, a Korean Government Agency, for the operation of the Partnership with Global Companies Program, which aims to identify Korean drug-discovery startups and support their business growth and global expansion. Under the terms of the MoU, KISED will provide overall management and research funding for the Partnership with Global Companies Program.
